Clinical Trial Update: Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial investigating azacitidine-based therapy for higher-risk myelodysplastic syndromes. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: MDS | Phase 2 | Status: UNKNOWN